羟可待酮
羟可待酮结构式
|
常用名 | 羟可待酮 | 英文名 | oxycodone |
|---|---|---|---|---|
| CAS号 | 76-42-6 | 分子量 | 315.364 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | 501.6±50.0 °C at 760 mmHg | |
| 分子式 | C18H21NO4 | 熔点 | 218-220° | |
| MSDS | N/A | 闪点 | 257.1±30.1 °C | |
| 符号 |
GHS07 |
信号词 | Warning |
| 中文名 | 羟可待酮 |
|---|---|
| 英文名 | oxycodone |
| 中文别名 | 羟考酮 | 二氢羟基可待因酮 |
| 英文别名 | 更多 |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 沸点 | 501.6±50.0 °C at 760 mmHg |
| 熔点 | 218-220° |
| 分子式 | C18H21NO4 |
| 分子量 | 315.364 |
| 闪点 | 257.1±30.1 °C |
| 精确质量 | 315.147064 |
| PSA | 59.00000 |
| LogP | 1.67 |
| 蒸汽压 | 0.0±1.4 mmHg at 25°C |
| 折射率 | 1.659 |
| 储存条件 | 2-8°C |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302 |
| 警示性声明 | P301 + P312 + P330 |
| 危害码 (欧洲) | F,T |
| 风险声明 (欧洲) | 11-23/24/25-39/23/24/25 |
| 安全声明 (欧洲) | 7-16-36/37-45 |
| 危险品运输编码 | UN 1544 |
| 包装等级 | II |
| 危险类别 | 6.1(a) |
| 羟可待酮上游产品 9 | |
|---|---|
| 羟可待酮下游产品 6 | |
CAS号508-54-3
CAS号115-37-7
CAS号124-90-3
CAS号5985-56-8
CAS号509-66-0
CAS号111355-33-0
CAS号865844-01-5![(1S,5R,13R,17S)-17-Hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one 4-oxide结构式](https://image.chemsrc.com/caspic/329/71539-52-1.png)
CAS号71539-52-1
CAS号1422-07-7
CAS号76-41-5
CAS号16590-41-3
CAS号52446-25-0|
Inhibition of TRPM8 channels reduces pain in the cold pressor test in humans.
J. Pharmacol. Exp. Ther. 351(2) , 259-69, (2014) The transient receptor potential (subfamily M, member 8; TRPM8) is a nonselective cation channel localized in primary sensory neurons, and is a candidate for cold thermosensing, mediation of cold pain... |
|
|
Spontaneous resolution of quadrilateral space syndrome: a case report.
Am. J. Phys. Med. Rehabil. 94(1) , e1-5, (2015) A case of quadrilateral space syndrome is presented, where a large near-circumferential glenoid labrum tear led to a paralabral cyst that dissected into the quadrilateral space and caused a compressiv... |
|
|
Rational prescribing.
Minn. Med. 96(3) , 4, (2013)
|
| Thecodine |
| Tekodin |
| Oxycodon |
| (5α)-14-hydroxy-17-methyl-3-(methyloxy)-4,5-epoxymorphinan-6-one |
| 14-hydroxy-dihydrocodeinone |
| Oxycon |
| Oxikon |
| Eubine |
| oxanest |
| (1S,5R,13R,17S)-17-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0.0.0]octadeca-7(18),8,10-trien-14-one |
| Eucodalum |
| Eukodal |
| oxycodone |
| Oxicon |
| (-)-14-Hydroxydihydrocodeinone |
| Dihydrone |
| percocet |
| (1S,5R,13R,17S)-17-Hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0.0.0]octadeca-7(18),8,10-trien-14-on |
| Tecodin |
| Thekodin |
| Percodan |
| Oxicone |
| Morphinan-6-one, 4,5α-epoxy-14-hydroxy-3-methoxy-17-methyl- |
| (1S,5R,13R,17S)-17-hydroxy-10-méthoxy-4-méthyl-12-oxa-4-azapentacyclo[9.6.1.0.0.0]octadéca-7(18),8,10-trién-14-one |
| Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5α)- |
| Morphinan-6-one,4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5a)- |
| Eutagen |
| (5α)-14-Hydroxy-3-methoxy-17-methyl-4,5-epoxymorphinan-6-one |
| 14-Hydroxydihydrocodeinone |
| Dihydrohydroxycodeinone |
| (5a)-4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one |
| endone |
| EINECS 200-960-2 |
